Login / Signup

Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis.

Naoto WakabayashiShiro WatanabeTakashige AbeJunki TakenakaKenji HirataRina KimuraKeita SakamotoNobuo ShinoharaKohsuke Kudo
Published in: Annals of nuclear medicine (2024)
In I-131 MIBG therapy for PPGLs, multiple administrations significantly increased only Grade 1 or 2 lymphopenia and leukopenia compared to single administration.
Keyphrases
  • stem cells